ELI LILLY & Co is 659.6x more valuable than Viridian Therapeutics, Inc.DE by market capitalization ($1.072 T vs $1.63 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VRDN | LLY |
|---|---|---|
| Market cap | $1.63 B | $1.072 T |
| US-listed rank | #2249 | #10 |
| Revenue (latest FY) | $4.00M | $65.18B |
| Net income (latest FY) | -$342.60M | $20.64B |
| Net margin | -8558.6% | 31.7% |
| P/E (trailing FY) | - | 51.9 |
| SEC filings | 794 | 989 |
ELI LILLY & Co is 659.6x more valuable than Viridian Therapeutics, Inc.DE by market capitalization ($1.072 T vs $1.63 B).
In their latest fiscal years, Viridian Therapeutics, Inc.DE reported $4.00M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Viridian Therapeutics, Inc.DE and ELI LILLY & Co, or browse the full rankings.